文献速递儿童青少年精神

MEF2C自闭症患者hiPSC神经元和大脑类器官中miRNA表达失调与兴奋性异常

Dysregulation of miRNA expression and excitation in MEF2C autism patient hiPSC-neurons and cerebral organoids.
PubMed 文献 · Mol Psychiatry · 2024-09-30

本研究首次利用MEF2C单倍剂量不足综合征(MHS)患者hiPSC来源的皮层神经元和大脑类器官,发现神经发生减少伴随miRNA介导的胶质发生通路激活,且MHS神经元存在网络级超兴奋性,突触与突触外活动过度导致兴奋/抑制失衡;突触外NMDA受体拮抗剂NitroSynapsin可纠正该异常电活动。

要点

  • MHS患者hiPSC皮层神经元和类器官中神经发生减少,伴miRNA介导的胶质发生通路激活。
  • MHS神经元表现网络级超兴奋性,突触与突触外活动过度导致兴奋/抑制失衡。
  • 突触外NMDA受体拮抗剂NitroSynapsin可纠正MHS神经元的异常电活动。

核心结论

  • MEF2C单倍剂量不足综合征患者hiPSC来源的皮层神经元和大脑类器官存在神经发生减少、miRNA介导的胶质发生通路激活及网络级超兴奋性。
  • 突触外NMDA受体拮抗剂NitroSynapsin可纠正MHS神经元中与异常表型相关的异常电活动。
  • MEF2C在神经发育中调控多个自闭症谱系障碍相关基因网络,提示治疗MHS缺陷可能对其它形式自闭症谱系障碍也有帮助。

研究设计与样本

  • 研究利用MHS患者hiPSC来源的皮层神经元和大脑类器官进行表征,为首次在人类背景下研究MHS特异性突变。

主要发现

  • MHS患者hiPSC来源的皮层神经元和类器官中神经发生减少,伴随miRNA介导的胶质发生通路激活。
  • MHS神经元表现网络级超兴奋性,突触与突触外活动过度,导致兴奋/抑制失衡。
  • 突触外NMDA受体拮抗剂NitroSynapsin可纠正MHS神经元中与异常表型相关的异常电活动。

临床怎么用

  • 作者认为,MEF2C在神经发育中调控多个自闭症谱系障碍相关基因网络,治疗MHS缺陷可能对其它形式自闭症谱系障碍也有帮助。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

MEF2C is a critical transcription factor in neurodevelopment, whose loss-of-function mutation in humans results in MEF2C haploinsufficiency syndrome (MHS), a severe form of autism spectrum disorder (ASD)/intellectual disability (ID). Despite prior animal studies of MEF2C heterozygosity to mimic MHS, MHS-specific mutations have not been investigated previously, particularly in a human context as hiPSCs afford. Here, for the first time, we use patient hiPSC-derived cerebrocortical neurons and cerebral organoids to characterize MHS deficits. Unexpectedly, we found that decreased neurogenesis was accompanied by activation of a micro-(mi)RNA-mediated gliogenesis pathway. We also demonstrate network-level hyperexcitability in MHS neurons, as evidenced by excessive synaptic and extrasynaptic activity contributing to excitatory/inhibitory (E/I) imbalance. Notably, the predominantly extrasynaptic (e)NMDA receptor antagonist, NitroSynapsin, corrects this aberrant electrical activity associated with abnormal phenotypes. During neurodevelopment, MEF2C regulates many ASD-associated gene networks, suggesting that treatment of MHS deficits may possibly help other forms of ASD as well.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Trudler D, Ghatak S, Bula M, et al. Dysregulation of miRNA expression and excitation in MEF2C autism patient hiPSC-neurons and cerebral organoids. Mol Psychiatry. 2024. PMID: 39349966. doi:10.1038/s41380-024-02761-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。